Five years. Three funds. One vision.
Three vehicles, one disciplined thesis — with Fund IV and an Africa-focused SPAC now launching.
Fund I
Global mandate across healthcare, HealthTech, MedTech, and drug discovery.
Fund II
Scaled deployment with larger cheques and deeper value-add support.
Fund III
India-focused vehicle targeting Series A & B opportunities in drug discovery, healthcare, and MedTech.
Fund IV
Next-generation global healthcare innovation vehicle.
Africa-Focused SPAC
Targeting high-potential healthcare and biotech opportunities across the African continent.
US$2.3 Billion under management.
US$950 Million committed across Funds I–III — every dollar guided by a single disciplined thesis, concentrated conviction in science-led healthcare and adjacent high-conviction domains.
With US$320 Million of dry powder remaining, OceansGled is expanding its investment mandate beyond healthcare — exploring deep technology, climate infrastructure, advanced materials, and other high-conviction domains where scientific rigor and patient capital create outsized returns.